AGENUS INC Repayments of Convertible Debt
AGENUS INC (AGEN) reported Repayments of Convertible Debt of $0 for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfConvertibleDebt · last filed 2016-03-15
- AGENUS INC repayments of convertible debt for the quarter ending 2014-03-31 was $833.33K.
- AGENUS INC repayments of convertible debt for the quarter ending 2013-12-31 was $20.00M, a 19900.00% increase year-over-year.
- AGENUS INC repayments of convertible debt for the quarter ending 2013-09-30 was $0.00.
- AGENUS INC repayments of convertible debt for the quarter ending 2013-06-30 was -$10.00M.
- AGENUS INC repayments of convertible debt for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- AGENUS INC repayments of convertible debt for fiscal 2013 was $10.00M.
- AGENUS INC repayments of convertible debt for fiscal 2012 was $0.00.
- AGENUS INC repayments of convertible debt for fiscal 2011 was $0.00.
| Period end | Repayments of Convertible Debt 3 month | Repayments of Convertible Debt 6 month | Repayments of Convertible Debt 9 month | Repayments of Convertible Debt 12 month |
|---|---|---|---|---|
| 2014-12-31 | $0.00 10-K · filed 2015-03-16 | |||
| 2014-03-31 | $833.33K 10-Q · filed 2014-05-09 | $20.83M derived: sum of 2 quarters · filed 2016-03-15 | $20.83M derived: sum of 3 quarters · filed 2016-03-15 | $10.83M derived: sum of 4 quarters · filed 2016-03-15 |
| 2013-12-31 | $20.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $20.00M derived: sum of 2 quarters · filed 2016-03-15 | $10.00M derived: sum of 3 quarters · filed 2016-03-15 | $10.00M 10-K · filed 2016-03-15 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -$10.00M derived: sum of 2 quarters · filed 2013-11-08 | -$10.00M 10-Q · filed 2013-11-08 | -$9.90M derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-06-30 | -$10.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$10.00M 10-Q · filed 2013-08-09 | -$9.90M derived: sum of 3 quarters · filed 2015-03-16 | -$10.00M derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-03-31 | $0.00 10-Q · filed 2014-05-09 | $100.00K derived: sum of 2 quarters · filed 2015-03-16 | $0.00 derived: sum of 3 quarters · filed 2015-03-16 | |
| 2012-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $0.00 derived: sum of 2 quarters · filed 2015-03-16 | $0.00 10-K · filed 2015-03-16 | |
| 2012-09-30 | -$100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -$100.00K 10-Q · filed 2013-11-08 | ||
| 2012-06-30 | $0.00 10-Q · filed 2013-08-09 | |||
| 2011-12-31 | $0.00 10-K · filed 2014-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |